Australia's Resonance Health jumps on over 3-fold rise in FY24 earnings
** Shares of Resonance Health RHT.AX rise as much as 21.2%
to A$0.063; set to gain most since Apr. 8
** The MedTech co posts operating EBITDA of A$1.12 mln
($761,376.00) for FY24, up 234% YoY
** Adds revenue up 95% YoY
** RHT has gained ~7% this week, on track for its best week
since week ending Aug. 2
** Stock down over 13% so far this year
($1 = 1.4710 Australian dollars)
(Reporting by Rajasik Mukherjee in Bengaluru)
((Rajasik.Mukherjee@thomsonreuters.com;))
Recent news on Resonance Health
See all newsAustralia's Resonance Health jumps on FY26 forecast hike
Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
Brief: Resonance Health Says Martin Blake Retires As Chair
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln
Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co